N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-4-hydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide
Structure Info
- Chemspace ID
- CSSS06256080418 (In-Stock Screening Compounds)
- MFCD
- MFCD00467190
- IUPAC Name
- N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-4-hydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide
- Mol formula
- C26H45NO21
- Mol weight
- 708 Da
- Catalog Number(s)
- AA01EAQI, AG01EATA, AR01EBIA, AX46614, BF46614, HY-N9445, L300118, SY071539, T75694, Y1187662
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -9.17
- Heavy atoms count
- 48
- Rotatable bond count
- 15
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.923
- Polar surface area (Å)
- 365
- Hydrogen bond acceptors count
- 21
- Hydrogen bond donors count
- 14
- Zoom the structure
- CSSS06256080418
Items Overall 8 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 1 mg | 60 | |
| MedChemExpress | 10 days | United States To: | 99 | 5 mg | 120 | |
| MedChemExpress | 10 days | United States To: | 99 | 10 mg | 180 | |
| MedChemExpress | 10 days | United States To: | 99 | 25 mg | 320 | |
Description: Names: Lacto-N-neotetraose; LNnT; Product Description: Lacto-N-neotetraose (LNnT) is an endogenous metabolite. Lacto-N-neotetraose can inhibit TNF-α induced IL-8 secretion in immature epithelial cells. Lacto-N-neotetraose has anti-inflammatory avtivity, and can improve the wound closure; Target: Endogenous Metabolite;TNF Receptor; CAS: 13007-32-4 | ||||||
| MedChemExpress EU | 10 days | Sweden To: | 99 | 1 mg | 60 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 120 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 180 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 320 | |
Description: Names: Lacto-N-neotetraose; LNnT; Product Description: Lacto-N-neotetraose (LNnT) is an endogenous metabolite. Lacto-N-neotetraose can inhibit TNF-α induced IL-8 secretion in immature epithelial cells. Lacto-N-neotetraose has anti-inflammatory avtivity, and can improve the wound closure; Target: Endogenous Metabolite;TNF Receptor; CAS: 13007-32-4 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire